essential guide to prescription drugs

Will lorcaserin (Lorquess) survive FDA scrutiny?

dr rybacki looking It's always difficult to predict how the FDA will perceive benefit to risk decisions and lorcaserin (Lorquess) is a singular example of this challenge. On one hand, the FDA has data showing that the medicine does work, while on th

Be honest about your pain

Dr. Rybacki skeptical  Pain is now the fifth vital sign. When you are in the hospital, pain is supposed to be regularly checked and if the pain is at an unacceptable level, treatment needs to be given and then the results from that treatment rechecked.

FDA advises consumers not to buy or use "RigiRx Plus" because of undeclared drug ingredient

 

2 men in kayak The FDA advised consumers NOT to purchase or use “RigiRx Plus, a product for sexual enhancement manufactured by Enhance Nutraceutical which is sold from various websites, including rigirxplus.com.

New test for Alzheimer's may give us an early wake up call

women The FDA approved a new agent for detecting Alzheimer's early. The PET scan agent is called florbetapir (Amyvid) and it just may be a new ticket to early detection and treatment !!!

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.